4 recruiting, 3 not yet recruiting. 6 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 3, Recruiting 3 |
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Long-Course Radiotherapy: new trials by email Literature Review of Long-Course Radiotherapy trials Research Report on Long-Course Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Trial of Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal Cancer Serine/Glycine-Restricted Diet, CAPOX Chemotherapy, Long-Course Radiotherapy - Locally Advanced Rectal Cancer | Phase 1 / Phase 2 | Not yet recruiting | Xuelei Ma MD | 126 | 2026-11-15 | 2026-11-03 |
| Arginine-Restricted Diet Combined With Chemoradiotherapy in Neoadjuvant Rectal Cancer: A Phase Ib/II Trial Arginine-Restricted Diet, CAPOX Chemotherapy, Long-Course Radiotherapy - Rectal Cancer Patients | Phase 1 / Phase 2 | Not yet recruiting | Xuelei Ma MD | 126 | 2026-10-31 | 2026-11-03 |
| Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer Modified Short-course radiotherapy, Long-course radiotherapy, Oxaliplatin - Locally Advanced Rectal Cancer | Phase 2 | Recruiting | Fujian Cancer Hospital | 130 | 2026-08-15 | 2026-10-01 |
| Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC Short-course radiotherapy, Long-course radiotherapy, Immunotherapy - Locally Advanced Rectal Adenocarcinoma, Neoadjuvant Chemoradiation | Phase 2 / Phase 3 | Not yet recruiting | Beijing Friendship Hospital | 342 | 2026-07-15 | 2026-06-17 |
| A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer Short-course radiotherapy, Long-course radiotherapy, Capecitabine - Rectal Cancer, Total Neoadjuvant Therapy | Phase 3 | Recruiting | Tao Zhang | 444 | 2026-05-15 | 2026-05-13 |
| Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC) Long-course radiotherapy, Oxaliplatin, Capecitabine - Locally Advanced Rectal Cancer, Neoadjuvant Therapy | Phase 2 | Recruiting | Fudan University | 138 | 2025-08-28 | 2025-09-02 |
| Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer Short-course radiotherapy, PD-1 antibody (Toripalimab), Long-course radiotherapy - Early Low Rectal Cancer | Phase 2 | Recruiting | Fudan University | 134 | 2024-04-01 | 2024-06-17 |
Rectal Neoplasms (1)
Fudan University (2) · Xuelei Ma MD (2) · Beijing Friendship Hospital (1) · Fujian Cancer Hospital (1) · Tao Zhang (1)
China (4)
Zhen Zhang, M.D, PH.D (2) · Chunkang Yang, MD (1) · Jiunluan Li, MD (1) · Zhenyu Lin, MD (1)